Vaccine trial on humans in Australia has been started by the US company

The US-based biotechnology company has started testing its coronavirus vaccine on people in Australia on Tuesday with the hope of releasing a proven vaccine this year. The company Novavax is going to inject 131 volunteers in the first phase of the trial testing is to check the safety of the vaccine and also to look for the signs of its effectiveness, as said by the research chief of the company, Dr Gregory Glenn. 

As of now many of the experimental vaccines against the coronavirus are at the early stages of the testing, most of them are in Chine, US, and Europe. 

Although animal testing has suggested that the vaccine is effective in a few low dosages. Novavax claimed that if the testing is successful then they can manufacture at least 100 million dosages this year and around 1.5 billion in 2021. 

The results of the first phase of clinical trials in Melbourne are expected to come in July. Most of the experimental vaccines are in progress in aiming to train the immune system to recognize the spike protein that attacks the protein studs of the outer surface of the virus. 

Novavax also added that the way they make a vaccine is that they just associate virus to the immune system and it dies automatically. Although it is the same process that the Novavax used to make a nanoparticle flu vaccine that has passed the last stage of testing. 

There are around 5 million cases of coronavirus worldwide. It has become important to make the vaccine as soon as possible.

Also See:

• Three Positive Cases Reported In Ludhiana In Last 24 Hours
• SBS Nagar Police Major Breakthrough in Sunpreet Singh Mangat Case
• N-95 Masks Now Covered Under Essential Commodity.
• Nitin Gadkari, Government Exploring New Financial Lending Institutions to Support Small-Scale Units
• Punjab CM Expressed Grief Over Demise of Hockey Legend Padma Shri Balbir Singh Sr.